Secretary Chris Wright visited Lawrence Livermore National Laboratory (LLNL) on May 28, experiencing firsthand the ...

Bildnachweis: ITM Isotope Technologies Munich SE, VC Magazin, Pixabay. As the global demand for targeted cancer therapies ...

US agency’s new policy could abruptly end studies of infectious diseases and cancer, leaving researchers scrambling for funds ...

The leading PD-1+ NSCLC Companies such as Arcus Biosciences, Akeso Biopharma, Biotheus, GlaxoSmithKline, AstraZeneca, Pfizer, Shandong Boan Biotechnology, Genor Biopharma and others. Promising PD-1+ ...

One provision stands out: the law’s “pill penalty.” The IRA doesn’t treat all medicines equally. “Small molecule” medicines, ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Under the deal, announced on May 20, Pfizer gains the opportunity to develop and sell the SSGJ-707 drug in markets outside of ...

Biopharmaceutical companies routinely cure diseases in animals during preclinical testing, yet those same therapies fail in human clinical trials nearly 95% of the time. By shifting from animals to an ...

"We've waited far too long for progress," writes an L.A. Times reader. "It took decades for today's experimental drugs to ...

At West, remarkably, Black patients have accounted for up to 50% of participants in clinical trials done through its facilities in Memphis and Germantown. Taking a few basic steps helped West reach ...

Mosquito season is returning to the Northeast, and with it comes not only a surge in buzzing pests but also perennial debates ...

New targeted therapies allow for the treatment of a disease that is already the fifth leading cause of fatal tumors globally ...